CIK 0001160308
- Non-accelerated filer
- Smaller reporting company
Savara Inc
Sign in to watch- Ticker
- SVRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 841318182
- Phone
- +51 285113796
- Business address
- 6836 BEE CAVE ROAD, BUILDING 3, SUITE 201, AUSTIN, TX, 78746
- Former names
- Mast Therapeutics, Inc., ADVENTRX PHARMACEUTICALS INC, BIOKEYS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-12-16 | Elam Nevan C Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2020-12-16 | Sun Ricky Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2020-12-15 | Elam Nevan C Director | Exercise or conversion | +2,930 | $0.52 | $2K | 24,612 |
| 2020-12-15 | Elam Nevan C Director | Exercise or conversion · Stock Option (Right to Buy) | −2,930 | 0 | ||
| 2020-09-15 | Pauls Matthew | Grant or award | +227,272 | 227,922 | ||
| 2020-09-15 | Pauls Matthew | Grant or award · Stock Option (Right to Buy) | +898,639 | 898,639 | ||
| 2020-03-10 | Sun Ricky Director | Grant or award · Stock Option (Right to Buy) | +12,000 | 12,000 | ||
| 2019-12-20 | Lowrance David L Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2019-12-20 | RAMSAY DAVID A Director | Grant or award · Stock Option (Right to Buy) | +12,000 | 12,000 | ||
| 2019-12-20 | Hawkins Richard J Director | Grant or award · Stock Option (Right to Buy) | +12,000 | 12,000 | ||
| 2019-12-20 | Pauls Matthew Director | Grant or award · Stock Option (Right to Buy) | +12,000 | 12,000 | ||
| 2019-12-20 | Jouhikainen Jaakko Taneli | Grant or award · Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2019-12-20 | Neville Robert N Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2019-12-20 | Elam Nevan C Director | Grant or award · Stock Option (Right to Buy) | +12,000 | 12,000 | ||
| 2019-12-20 | van Es-Johansson An Director | Grant or award · Stock Option (Right to Buy) | +12,000 | 12,000 | ||
| 2019-12-20 | McCracken Joseph S Director | Grant or award · Stock Option (Right to Buy) | +12,000 | 12,000 | ||
| 2019-11-26 | Chowdhury Badrul A. Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +300,000 | 300,000 | ||
| 2019-11-26 | Chowdhury Badrul A. Chief Medical Officer | Grant or award · Restricted Stock Units | +200,000 | 200,000 | ||
| 2019-07-05 | McCracken Joseph S Director | Exercise or conversion | +21,682 | $0.82 | $18K | 81,548 |
| 2019-07-05 | McCracken Joseph S Director | Exercise or conversion | +2,930 | $0.82 | $2K | 84,478 |
Page 14 of 20 · 390 trades